CANBRIDGE PHARM.DL-00001 Cash Flow Quality Index
CANBRIDGE PHARM.DL-00001 cash flow quality index. CANBRIDGE PHARM.DL-00001 (MF1) has a Cash Flow Quality Index of -2.58x as of December 2025. Operating cash flow of €-38.21 Million is below net income of €14.82 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of CANBRIDGE PHARM.DL-00001 to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of CANBRIDGE PHARM.DL-00001 (2025–2025)
Cash flow quality index of CANBRIDGE PHARM.DL-00001 from 2025 to 2025. Historical Cash Flow Quality Index for CANBRIDGE PHARM.DL-00001 across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore CANBRIDGE PHARM.DL-00001 (MF1) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
CANBRIDGE PHARM.DL-00001 Cash Flow Quality Index by Year (2025–2025)
CANBRIDGE PHARM.DL-00001 cash flow quality index by year from 2025 to 2025. Year-by-year earnings quality comparison for CANBRIDGE PHARM.DL-00001. For the full cash flow conversion analysis, see MF1 cash flow metrics.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -2.58x | €-38.21 Million | €14.82 Million | — |